EMPLOYMENT AGREEMENT
                                --------------------


         EMPLOYMENT AGREEMENT dated as of July 1, 1999 (the "Agreement"),
between Orthofix International N.V., a corporation organized under the laws of
the Netherlands Antilles (the "Company"), and Edgar Wallner (the "Executive").


         WHEREAS, the Company and the Executive entered into an employment
agreement dated as of March 31, 1992 (the "Prior Agreement"); and

         WHEREAS, the Company and the Executive desire to amend the Prior
Agreement in its entirety effective as of July 1, 1999 as hereafter set forth;

         NOW, THEREFORE, in consideration of the covenants and agreements
hereinafter set forth, the parties hereto agree as follows:

     1.  EMPLOYMENT AND DUTIES

         1.1 General. The Company hereby employs the Executive, and the
Executive agrees to serve, as President and Chief Executive Officer of the
Company or any other position proposed by the Board of Directors of the Company
(the "Board") and accepted by him, upon the terms and conditions herein
contained. The Executive also agrees to serve, if elected, as an officer or
director of any direct or indirect subsidiary of the Company, in each such case
at no compensation in addition to that provided for in this Agreement.

         1.2 Services. The Executive shall provide services to the Company and
its subsidiaries pursuant to this Agreement for at least 208 days in each
calendar year. Anything in this Agreement to the contrary notwithstanding, the
Executive may, with the consent of the Board, engage in other business matters
that do not interfere materially with his duties to the Company pursuant to this
Agreement. In addition, this Agreement shall not be construed to preclude the
Executive from devoting time to civic and community activities or the management
of personal investments so long as such activities do not interfere with the
performance of his duties hereunder.

         1.3 Term of Employment. The Executive's employment under this Agreement
shall commence on July 1, 1999 (the "Effective Date") and shall terminate on the
earlier of (i) the third anniversary of the Effective Date, or (ii) termination
of the Executive's employment pursuant to Sections 4 or 5 of this Agreement.
This initial three-year term, however, shall be automatically extended without
further action of either party for one or more additional one-year periods,
unless written notice of either party's intention not to extend has been given
to the other party hereto at least six months prior to the expiration of the
then-effective term (the period






                                       2

commencing on the Effective Date and ending on the third anniversary thereof,
or such later date to which the term of the Executive's employment shall have
been extended, is hereinafter referred to as the "Employment Term").

     2.  COMPENSATION

         2.1 Base Salary and Bonus. The base salary and bonus compensation, if
any, to be paid to the Executive shall be determined from time to time by the
Board.

         2.2 Share Options. The Executive has heretofore received grants of
options under the Company's Executive Share Option Plan (the "Executive Plan")
to purchase a certain number of the Company's Common Shares, 100,000 of which
have been assigned to other parties. All such options shall have the terms and
be subject to the conditions specified therefor in the Executive Plan and any
award agreement relating to the options granted to the Executive thereunder.

     3.  EMPLOYEE BENEFITS

         3.1 General. The Executive shall be included, to the extent eligible
thereunder by virtue of his position, tenure, salary, and other qualifications
(which may include nationality and residence), in all employee benefit plans,
programs or arrangements (including, without limitation, any plans, programs or
arrangements providing for retirement benefits, incentive compensation, profit
sharing, vacation, bonuses, disability benefits, health and life insurance, or
vacation and paid holidays) established by the Company for, or made available
to, its senior executives. For the avoidance of doubt, such benefits include,
but are not limited to, 16 days of annual vacation plus statutory holidays.

         3.2 Reimbursement of Expenses. The Company will reimburse the
Executive for reasonable travel and other business expenses incurred by him in
the fulfillment of his duties hereunder upon presentation by the Executive of an
itemized account of such expenditures, in accordance with Company practices
consistently applied.

     4.  TERMINAT10N OF EMPLOYMENT

         4.1 Termination Without Cause; Resignation For Good Reason

         4.1.1 General. If, prior to the expiration of the Employment Term, the
Executive's employment is terminated by the Company without Cause (as defined in
Section 4.3), or if the Executive resigns from his employment hereunder for Good
Reason (as defined in Section 4.4), the Executive shall be entitled under this
Agreement to convert his employment to a guaranteed consultancy at the
Executive's sole discretion for the remainder of the Employment Term. Such
consultancy may be terminated by the Company only for Cause (as defined in
Section 4.3) and shall remain an obligation of the Company notwithstanding a
Change in Control (as defined in





                                       3


Section 4.5). As a consultant, the Executive shall perform such services as are
mutually agreed between the Executive and the Company and the Executive shall
honor the covenants in Section 6.0. Unless otherwise determined by the Board,
the compensation to be paid the Executive shall be US$50,000 per annum. Nothing
in this Agreement shall be construed to diminish or alter the rights of the
Executive provided for in the Company's Staff Share Option Plan (the "Staff
Plan") and the Executive Plan in the event of his termination without Cause or
resignation for Good Reason in any options granted to him under such Plans.
Notwithstanding the conversion of the Executive's employment to a guaranteed
consultancy, the Executive shall be deemed to have remained in the employ of the
Company within the meaning of the Executive Plan and Staff Plan and all
unvested options granted in the Executive's Share Option Agreement(s) shall vest
on the schedule(s) set in that (those) agreement(s). For determining the
exercise date of the options that vest during the period of the Executive's
consultancy, the date of termination of employment shall be the date of
expiration of the guaranteed consultancy under this Agreement.

         4.1.2 Date of Termination or Resignation. The date of termination of
employment without Cause shall be the date specified in a written notice of
termination to the Executive. The date of resignation for Good Reason shall be
the date specified in a written notice of resignation from the Executive to the
Company, or, if no date is specified therein, 10 business days after receipt by
the Company of notice of resignation from the Executive, provided, however, that
no such written notice shall be effective unless the cure period specified in
Section 4.4 has expired without the Company having corrected, to the reasonable
satisfaction of the Executive, the event or events subject to cure.

         4.1.3 Options. Nothing in this Agreement shall be construed to diminish
or alter the rights of the Executive provided for in the Staff Plan and the
Executive Plan in the event of his termination without Cause or resignation for
Good Reason in any options granted to him under such Plans.

         4.2 Termination for Cause; Resignation Without Good Reason.

         4.2.1 General. If, prior to the expiration of the Employment Term, the
Executive's employment is terminated by the Company for Cause, or if the
Executive resigns from his employment hereunder without Good Reason, the
Executive shall be entitled under this Agreement only to payment of his base
salary earned through and including the date of termination or resignation. The
Executive shall have no further right to receive any other compensation, or
to participate in any other plan, arrangement, or benefit, after such
termination or resignation of employment, provided, however, that nothing in
this Agreement shall be construed to diminish or alter the rights of the
Executive provided for in the Staff Plan and the Executive Plan in the event of
his termination for Cause or resignation without Good Reason in any options
granted to him under such Plans.





                                       4


         4.2.2 Date of Termination or Resignation. The date of termination for
Cause shall be the date specified in a written notice of termination provided
for in Section 4.2.3, provided, however, that no such written notice shall be
effective unless the cure period specified in Section 4.2.3 has expired without
the Executive having corrected, to the reasonable satisfaction of the Board, the
event or events subject to cure. The date of resignation without Good Reason
shall be the date specified in a written notice of resignation from the
Executive to the Company, or, if no date is specified therein, 10 business days
after receipt by the Company of notice of resignation from the Executive.

         4.2.3 Notice of Termination. Termination of the Executive's employment
for Cause shall be communicated by delivery to the Executive of a copy of a
resolution duly adopted by the affirmative vote of not less than a majority of
the entire membership of the Board at a meeting of the Board called and held for
such purpose (after reasonable notice to the Executive and reasonable
opportunity for the Executive, together with the Executive's counsel, to be
heard before the Board prior to such vote), finding that in the good faith
opinion of the Board an event constituting Cause for termination in accordance
with Section 4.3 has occurred and specifying the particulars thereof (a "Notice
of Termination"). If the event constituting Cause for termination is of a type
specified in Section 4.3(iii), the Executive shall have 20 business days from
the date of receipt of such Notice of Termination to effect a cure of the event
described therein and, upon cure thereof by the Executive to the reasonable
satisfaction of the Board, such event shall no longer constitute Cause for
purposes of this Agreement.

         4.3 Cause. Termination for "Cause" means termination of the Executive's
employment because of the Executive's (i) involvement in fraud, misappropriation
or embezzlement related to the business or property of the Company, (ii)
conviction for, or guilty plea to, a felony or a crime of similar gravity in the
jurisdiction where such conviction or guilty plea occurs, or (iii) willful
breach of any of the material terms of this Agreement (it being acknowledged by
the parties that such material terms include, without limitation, the
Executive's covenants pursuant to Sections 1.2 and 6).

         4.4 Good Reason. For purposes of this Agreement, "Good Reason" means
the Executive's good faith determination that any of the following has occurred:
(i) any significant diminution, without the Executive's prior written consent,
in the Executive's position, duties, responsibilities, power, title or office,
(ii) any breach by the Company of any material provision of this Agreement, or
(iii) the circumstances described in Section 4.5. Unless the Executive provides
written notification of an event described in clause (i) or (ii) of the
preceding sentence within 30 days after the Executive knows or has reason to
know of the occurrence of any such event, the Executive shall be deemed to have
consented thereto and such event shall no longer constitute Good Reason for
purposes of this Agreement. If the Executive provides such written notice to the
Company, the Company shall have 20 business days from the date of receipt of
such notice to effect a cure of the event described therein and, upon cure
thereof by the Company to





                                       5


the reasonable satisfaction of the Executive, such event shall no longer
constitute Good Reason for purposes of this Agreement.

         4.5 Change in Control. (a) In the event of a Change in Control (as
defined in subsection (b) below), the Executive agrees that he shall continue as
President and Chief Executive Officer of the Company (or such other position
that he occupied pursuant to Section 1.1 before the Change in Control) for a
period of at least six months from the effective date of such Change in Control,
unless his employment shall be earlier terminated by the Company. For a period
of three months following such six-month period, the Executive shall have the
right to resign his employment hereunder on 10 business days' written notice to
the Company. Any such resignation shall be treated as a resignation for Good
Reason for purposes of this Agreement and for purposes of any other arrangement
between the Company and the Executive which incorporates by reference the
definition of "Good Reason" set forth in this Agreement.

         (b) For purposes of this Agreement, a "Change in Control" means:

         (i) the acquisition by any individual, entity or group of beneficial
ownership (within the meaning of Rule 13d-3 promulgated under the United States
Securities Exchange Act of 1934, as amended) of more than 50% of the
then-outstanding voting securities of the Company entitled to vote generally in
the election of directors or of equity securities having a value equal to more
than 50% of the total value of all equity securities of the Company, provided,
however, that the following acquisitions of shares or other securities shall not
constitute a Change in Control: (I) any acquisition directly from the Company,
(II) any acquisition by the Company, and (III) any acquisition by an employee
benefit plan (or related trust) sponsored or maintained by the Company or any of
its affiliates; or

         (ii) individuals who as of the effective date of this Agreement
constitute the Board (the "Incumbent Board") cease for any reason to constitute
at least a majority of the Board, except that any director whose election or
nomination for election was approved by the vote of at least a majority of
directors then comprising the Incumbent Board shall be considered as though such
individual were a member of the Incumbent Board, but excluding for this purpose
any individual whose initial assumption of office occurs as the result of either
an actual or threatened election contest or other actual or threatened
solicitation of proxies or consents by or on behalf of a person other than the
Board.

     5.  DEATH OR PERMANENT DISABILITY

         5.1 Death. If the Executive's employment hereunder is terminated by
death, the Executive's estate shall be entitled only to payment of the
Executive's base salary earned through and including the date of the Executive's
death and the Company shall have no further obligations under this Agreement,
provided, however, that nothing in this Agreement shall be





                                       6


construed to diminish or alter the rights of the Executive's estate provided
for in the Staff Plan and the Executive Plan in the event of his death in any
options granted to him under such Plans.

         5.2 Permanent Disability. In the event that the Board terminates the
Executive's employment as a result of a physical or mental incapacity which
substantially prevents the Executive from performing his duties as an employee
and that has continued at least six months and can reasonably be expected to
continue indefinitely, the Executive shall be entitled only to payment of
Executive's base salary earned through and including the last day of such
six-month period. The Company shall have no further obligations under this
Agreement, except as may be provided under any long-term disability policy
maintained by the Company and in which the Executive participated at the time of
his termination of employment, provided, however, that nothing in this Agreement
shall be construed to diminish or alter the rights of the Executive provided for
in the Staff Plan and the Executive Plan in the event of such incapacity in any
options granted to him under such Plans. Any dispute as to whether or not the
Executive is incapacitated within the meaning of the preceding sentence shall be
resolved by a physician reasonably satisfactory to the Board and the Executive.

     6.  CONFLICT OF INTEREST, NONINTERFERENCE AND CONFIDENTIALITY

         6.1 Conflict of Interest. During the period of the Executive's
employment hereunder, the Executive shall not, unless he receives the prior
written consent of the Company, directly or indirectly, own an interest in,
manage, operate, join, control, lend money or render financial or other
assistance to or participate in or be connected with, as an officer, employee,
partner, stockholder, consultant or otherwise (other than as a stockholder or
investor holding not more than 5% interest) of, any individual, partnership,
firm, corporation or other business organization or entity that, at such time,
is engaged in the business of producing or distributing orthopaedic products
manufactured, distributed or sold by the Company; provided, however, that prior
written consent is hereby deemed to have been given for the Executive's interest
in Arrow Medical Limited.

         6.2 No Solicitation or Interference. During the period of three years
following the Executive's voluntary or involuntary termination of employment for
any reason, the Executive shall not, whether for his own account or for the
account of any other individual, partnership, firm, corporation or other
business organization, directly solicit, endeavor to entice away from the
Company, directly or indirectly induce to terminate employment or business
relations with the Company, or otherwise interfere with the relationship of the
Company with, any person or entity who is, or was within the one-year period
ending on the Executive's date of termination, (a) employed by or otherwise
engaged to perform services for the Company, or (b) a customer or client of the
Company.

         6.3 Trade Secrets. During the period of the Executive's employment
hereunder and at all times thereafter, the Executive shall hold in secrecy for
the Company all trade secrets and





                                       7


other confidential information relating to the Company's business and affairs
that may come to his knowledge or have come to his knowledge while heretofore
employed by the Company, including but not limited to matters of a technical
nature, such as scientific, trade or engineering secrets, "know-how", formulae,
secret processes or machines, inventions, and research projects, and matters of
a business nature, such as, information about costs, profits, markets, sales,
lists of customers and suppliers, and other information of a similar nature, and
plans for future development. Notwithstanding the preceding sentence, the
Executive shall not be required to maintain the confidentiality of any
information which (i) is or becomes available to the public other than as a
result of disclosure by the Executive in violation of this Section 6.3 or (ii)
the Executive is required to disclose under any applicable laws, regulations or
directives of any government agency, tribunal or authority having jurisdiction
in the matter or under subpoena or other process of law. Except as required in
the performance of his duties to the Company under this Agreement, the Executive
shall not use for his own benefit or disclose to any person, directly or
indirectly, any trade secrets or other confidential information relating to the
Company's business and affairs unless such use or disclosure has been
specifically authorized in writing by the Company in advance.

         6.4 Return of Documents and Property. Upon the termination of the
Executive's employment by the Company, the Executive (or his heir or personal
representative) shall deliver to the Company (a) all documents and materials
containing trade secrets and other confidential information relating to the
Company's business and affairs, and (b) all other documents, materials and other
property belonging to the Company or its affiliated companies that are in the
possession or under the control of the Executive.

         6.5 Remedies. The Executive acknowledges that a breach of any of the
covenants contained in this Section 6 may result in material irreparable injury
to the Company or its affiliates or subsidiaries for which there is no adequate
remedy at law and that it will not be possible to measure damages for such
injuries precisely. Accordingly, the Company shall be entitled to the remedies
of injunction and specific performance, or either of such remedies, as well as
all other remedies to which the Company may be entitled, at law, in equity or
otherwise.

     7.  MISCELLANEOUS

         7.1 Notices. Any notice required or permitted under this Agreement
shall be given in writing and shall be deemed to have been effectively made or
given if personally delivered, or if telegraphed, telexed or cabled to the other
party at its address set forth below in this Section 7.1, or at such other
address as such party may designate by written notice to the other party hereto.
Any effective notice hereunder shall be deemed given on the date personally
delivered or on the date telegraphed, telexed, or cabled, as the case may be, at
the following address:

            (i) If to the Company:





                                       8

                Orthofix International N.V.
                7 Abraham de Veerstraat
                Curacao
                Netherlands Antilles

           (ii) If to the Executive:

                Mr. Edgar Wallner
                Somerville
                Bray Road
                Bray Berks SL6 1UQ
                United Kingdom

            7.2 Disputes. Any dispute arising out of or in connection with this
Agreement, including any question regarding its existence, validity, or
termination, shall be referred to and finally resolved by arbitration under the
LCIA Rules, which Rules are deemed to be incorporated by reference into this
Section 7.2. The number of arbitrators shall be one. The seat, or legal place,
of arbitration shall be the City of London. The language to be used in the
arbitral proceedings shall be English. The decision in such arbitration shall be
final and conclusive on the parties and judgment upon such decision may be
entered in any court having jurisdiction thereof. Pending resolution of any
dispute, any amounts payable pursuant to the terms of the Agreement shall be
made as and when due.

            7.3 Severability. If a court of competent jurisdiction determines
that any term or provision hereof is invalid or unenforceable, (a) the remaining
terms and provisions hereof shall be unimpaired and (b) such court shall have
the authority to replace such invalid or unenforceable term or provision with a
term or provision that is valid and enforceable and that comes closest to
expressing the intention of the invalid or unenforceable term or provision.

            7.4 Entire Agreement. This Agreement represents the entire agreement
of the parties and shall supersede any and all previous contracts, arrangements
or understandings between the Company and the Executive relating to the
Executive's employment by the Company, except that this Agreement shall not
alter or impair any of the Executive's rights under awards made to him pursuant
to the Staff Plan or the Executive Plan. The Agreement may be amended at any
time only by mutual agreement of the parties hereto.

            7.5 Withholding. The Company shall be entitled to withhold, or cause
to be withheld, from payment any amount of withholding taxes required by law
with respect to payments made to the Executive in connection with his
employment.





                                       9


            7.6 Governing Law. This Agreement shall be construed, interpreted,
and governed in accordance with the laws of the Netherlands Antilles without
reference to rules relating to conflict of law.

            7.7 Assignment and Successors. This Agreement shall be binding upon
and inure to the benefit of, and shall be enforceable by the Executive and the
Company, their respective heirs, executors, administrators and assigns. In the
event the Company is merged, consolidated, liquidated by a parent corporation,
or otherwise combined into one or more corporations, the provisions of this
Agreement shall be binding upon and inure to the benefit of the parent
corporation or the corporation resulting from such merger or to which the assets
shall be sold or transferred, which corporation from and after the date of such
merger, consolidation, sale or transfer shall be deemed to be the Company for
purposes of this Agreement. In the event of any other assignment of this
Agreement by the Company, by operation of law or otherwise, the Company shall
remain primarily liable for its obligations hereunder. This Agreement shall not
be assignable by the Executive.

            7.8 Headings. The headings of sections herein are included solely
for convenience of reference and shall not control the meaning or
interpretation of any of the provisions of this Agreement

            7.9 Counterparts. This Agreement may be executed by either of the
parties hereto in counterparts, each of which shall be deemed to be an original,
but all such counterparts shall together constitute one and the same instrument.

            IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the day and year first above written.

                                              ORTHOFIX INTERNATIONAL N.V.



By:                                           By:  /s/ Jerry C. Benjamin
   -----------------------                       -------------------------------
Name:                                            Name:  Jerry C. Benjamin
Title:                                           Title:  Director



                                                   /s/ Edgar Wallner
                                                 -------------------------------
                                                         Edgar Wallner